These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 8088338)
1. Induction of protective cytotoxic T cells with viral proteins. Bachmann MF; Kündig TM; Freer G; Li Y; Kang CY; Bishop DH; Hengartner H; Zinkernagel RM Eur J Immunol; 1994 Sep; 24(9):2228-36. PubMed ID: 8088338 [TBL] [Abstract][Full Text] [Related]
2. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501 [TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex--dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Schulz M; Aichele P; Vollenweider M; Bobe FW; Cardinaux F; Hengartner H; Zinkernagel RM Eur J Immunol; 1989 Sep; 19(9):1657-67. PubMed ID: 2477254 [TBL] [Abstract][Full Text] [Related]
4. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205 [TBL] [Abstract][Full Text] [Related]
6. Plasmid DNA vaccines are effective in the absence of IFNgamma. Hassett DE; Zhang J; Whitton JL Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092 [TBL] [Abstract][Full Text] [Related]
7. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates. Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415 [TBL] [Abstract][Full Text] [Related]
8. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins. Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330 [TBL] [Abstract][Full Text] [Related]
9. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens. Browning MJ; Huang AS; Reiss CS J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes. Bachmann MF; Lutz MB; Layton GT; Harris SJ; Fehr T; Rescigno M; Ricciardi-Castagnoli P Eur J Immunol; 1996 Nov; 26(11):2595-600. PubMed ID: 8921944 [TBL] [Abstract][Full Text] [Related]
11. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain. Battegay M; Bachmann MF; Burhkart C; Viville S; Benoist C; Mathis D; Hengartner H; Zinkernagel RM Cell Immunol; 1996 Jan; 167(1):115-21. PubMed ID: 8548834 [TBL] [Abstract][Full Text] [Related]
12. IL-12 is not required for induction of type 1 cytokine responses in viral infections. Oxenius A; Karrer U; Zinkernagel RM; Hengartner H J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells. Battegay M; Kyburz D; Hengartner H; Zinkernagel RM Eur J Immunol; 1993 Dec; 23(12):3236-41. PubMed ID: 8258339 [TBL] [Abstract][Full Text] [Related]
15. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants. Byrne JA; Ahmed R; Oldstone MB J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788 [TBL] [Abstract][Full Text] [Related]
16. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447 [TBL] [Abstract][Full Text] [Related]